Ignite Creation Date:
2024-05-06 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 12:54 PM
Study NCT ID:
NCT03673787
Status:
UNKNOWN
Last Update Posted:
2022-04-08
First Post:
2018-09-10
Brief Title:
A Trial of Ipatasertib in Combination With Atezolizumab
Sponsor:
Institute of Cancer Research United Kingdom
Organization:
Institute of Cancer Research United Kingdom
Organization Data
Organization:
Institute of Cancer Research United Kingdom
Class:
OTHER
Study ID:
CCR4720
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute of Cancer Research United Kingdom
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |